The US’s Centers for Disease Control and Prevention (CDC) will distribute 200 test kits for Wuhan coronavirus to domestic labs, and another 200 test kits to international labs.
Each test kit can perform 700-800 patient samples.
This will allow for enhanced capacity for testing by early next week, Dr. Nancy Messonnier, director of the CDC’s National Center for Immunization and Respiratory Diseases, told reporters Wednesday.
Messonnier said she expected these kits will result in states announcing their own confirmed cases, rather than waiting for confirmation from the CDC.
Previously, the CDC was the only lab in the United States capable of testing for the novel coronavirus.
The diagnostic is authorized to be used for patients who meet CDC criteria for testing, and by qualified labs designated by the CDC or certified to perform high-complexity tests.
It’s known as a reverse transcriptase polymerase chain reaction test and can detect Wuhan coronavirus from nasal or oral swabs.
Negative results do not preclude infection with the virus, the FDA noted in a press release, adding that negative results must be combined with clinical observations, patient history and epidemiological information.
As of Wednesday, the CDC has listed 293 people under investigation for the novel coronavirus in 36 states.
Of those, 11 have tested positive, 206 negative and 76 are still pending. These numbers are cumulative since January 21.
Six cases have been confirmed in California, one in Massachusetts, one in Washington state, one in Arizona and two in Illinois. This includes two instances of known person-to-person transmission, one in Illinois and one in California.